OCT Angiography and NRAI in Dementia

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 14, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Alzheimer DiseaseDementiaMild Cognitive Impairment
Interventions
DEVICE

Optical Coherence Tomography Angiography (OCTA) Imaging

Optical coherence tomography is a non-invasive imaging technology that provides cross-sectional images of tissues in micron-scale resolution. The angiography component of this device allows for evaluation of blood vessel and blood flow changes in the eye. The Solix device with AngioVue software will be used to detect these blood vessel and flow changes as well as protein deposits in the retinal layers.

DEVICE

Noninvasive Retinal Amyloid Imaging (NRAI)

The Spectralis will be used for NRAI. This system uses a special light source and optical filters to detect fluorescence of amyloid proteins in the eye.

Trial Locations (1)

97239

RECRUITING

Oregon Health & Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER